L'impact du mounjaro va bien au-delà de la perte de poids – l'étude trouve une protection pour le cœur et le système immunitaire

Factual coreconfirmed by several independent voices

Insufficient core: not enough independent confirmations to retain a shared fact.

Reported detailssecondary facts, each attributed to its source

• 35 353 d'entre eux ont commencé le traitement par le tirzépatide, 17 618 avec la sitagliptine.

  according to Frankfurter Rundschau +1

• Chez la sitagliptine, elle était de 4,4 %.

  according to Frankfurter Rundschau +1

Disputedincompatible versions — to verify

No factual contradiction detected between sources.

Framing by sidesame fact, different words — loaded terms highlighted

No notable framing divergence.

Blind spotwhat one side keeps silent

No blind spot detected: every side covers the same facts.

Sources2 sources cross-checked

Images from the sourcesThe photos each outlet chose to illustrate this story — click to open the article.

• Münchner Merkur